UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C FORM 8-K. Current Report

Similar documents
CTS Announces First Quarter 2018 Results. Strong sales and earnings growth

NEWELL BRANDS INC. (Exact name of registrant as specified in its charter)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C FORM 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC FORM 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC FORM 8-K

Facebook, Inc. (Exact Name of Registrant as Specified in Charter)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC FORM 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC FORM 8-K

LKQ CORPORATION (Exact name of registrant as specified in its charter)

GRANITE CONSTRUCTION INCORPORATED (Exact Name of Registrant as Specified in Charter)

MASCO CORP /DE/ FORM 8-K. (Current report filing) Filed 02/09/15 for the Period Ending 02/09/15

Facebook, Inc. (Exact Name of Registrant as Specified in Charter)

LKQ CORPORATION (Exact name of registrant as specified in its charter)

Morningstar Document Research

Facebook, Inc. (Exact Name of Registrant as Specified in Charter)

LKQ CORPORATION (Exact name of registrant as specified in its charter)

R. R. DONNELLEY & SONS COMPANY (Exact name of Registrant as Specified in Its Charter)

Tableau Software, Inc.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC FORM 8-K

CORELOGIC, INC. (Exact Name of the Registrant as Specified in Charter)

CLARUS CORPORATION (Exact name of registrant as specified in its charter)

CISCO SYSTEMS, INC. (Exact name of registrant as specified in its charter)

Aspen Aerogels, Inc. (Exact name of Registrant as Specified in Its Charter)

IPG PHOTONICS CORPORATION (Exact name of registrant as specified in its charter)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C FORM 8-K CURRENT REPORT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C FORM 8-K

Jacobs Engineering Group Inc. (Exact name of Registrant as specified in its charter)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C FORM 8-K

LKQ CORPORATION (Exact name of registrant as specified in its charter)

STURM, RUGER & COMPANY, INC. (Exact Name of Registrant as Specified in its Charter)

LKQ CORPORATION (Exact name of registrant as specified in its charter)

MICROCHIP TECHNOLOGY INCORPORATED (Exact name of registrant as specified in its charter)

SECURITIES & EXCHANGE COMMISSION EDGAR FILING. MusclePharm Corp. Form: 8-K. Date Filed:

Intercontinental Exchange, Inc. (Exact Name of Registrant as Specified in its Charter)

GRUBHUB INC. (Exact name of Registrant as Specified in Its Charter)

LOWES COMPANIES INC. FORM 8-K (Unscheduled Material Events) Filed 5/16/2005 For Period Ending 5/16/2005

ARMSTRONG FLOORING, INC. (Exact name of registrant as specified in its charter)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION FORM 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C FORM 8-K CURRENT REPORT

SECURITIES & EXCHANGE COMMISSION EDGAR FILING. MusclePharm Corp. Form: 8-K. Date Filed:

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C FORM 8-K

FTD COMPANIES, INC. FORM 8-K. (Current report filing) Filed 05/07/14 for the Period Ending 05/07/14

TRACK GROUP, INC. (Exact name of Registrant as specified in its Charter)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC FORM 8-K. Masco Corporation (Exact name of Registrant as Specified in Charter)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C FORM 8-K

ARMSTRONG FLOORING, INC. (Exact name of registrant as specified in its charter)

Jacobs Engineering Group Inc. (Exact name of Registrant as specified in its charter)

CISCO SYSTEMS, INC. (Exact name of registrant as specified in its charter)

Matrix Service Company (Exact Name of Registrant as Specified in Its Charter)

AVNET, INC. (Exact name of registrant as specified in its charter)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC FORM 8-K

FORM 8-K GENERAL COMMUNICATION INC - GNCMA. Filed: October 29, 2009 (period: October 29, 2009)

NUANCE COMMUNICATIONS, INC. (Exact name of registrant as specified in its charter)

HEALTHSTREAM INC FORM 8-K. (Current report filing) Filed 10/23/07 for the Period Ending 10/23/07

P. H. Glatfelter Company

POLAR POWER, INC. (Exact Name of Registrant as Specified in Charter)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C FORM 8-K CURRENT REPORT

CLEAR CHANNEL OUTDOOR HOLDINGS, INC.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC FORM 8-K

PARKER HANNIFIN CORP

CISCO SYSTEMS, INC. (Exact name of registrant as specified in its charter)

Robert Half International Inc.

SECURITIES & EXCHANGE COMMISSION EDGAR FILING RELM WIRELESS CORP. Form: 8-K. Date Filed:

FORM 8-K. MGC Diagnostics Corporation (Exact name of registrant as specified in its charter)

UNITED TECHNOLOGIES CORPORATION (Exact name of registrant as specified in its charter)

CISCO SYSTEMS, INC. (Exact name of registrant as specified in its charter)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC FORM 8-K. Masco Corporation (Exact name of Registrant as Specified in Charter)

FORM 8-K EL POLLO LOCO HOLDINGS, INC.

J.Crew Group, Inc. (Exact name of registrant as specified in its charter)

AMERICAN EAGLE OUTFITTERS, INC. (Exact name of registrant as specified in its charter)

ULTA SALON, COSMETICS & FRAGRANCE, INC. (Exact Name of Registrant as Specified in its Charter)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC FORM 8-K. Masco Corporation (Exact name of Registrant as Specified in Charter)

Lancaster Colony Corporation

SECURITIES & EXCHANGE COMMISSION EDGAR FILING. MusclePharm Corp. Form: 8-K. Date Filed:

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC FORM 8-K

CLARUS CORPORATION (Exact name of registrant as specified in its charter)

KBR, INC. (Exact name of registrant as specified in its charter)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C FORM 8-K CURRENT REPORT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C FORM 8-K CURRENT REPORT

QUEST RESOURCE HOLDING CORPORATION (Exact Name of Registrant as Specified in Charter)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C FORM 8-K CURRENT REPORT

ADTRAN, Inc. (Exact name of Registrant as Specified in Its Charter)

ULTA SALON, COSMETICS & FRAGRANCE, INC. (Exact Name of Registrant as Specified in its Charter)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C FORM 8-K. Aon plc (Exact Name of Registrant as Specified in Charter)

IDEXX LABORATORIES, INC. (Exact name of registrant as specified in its charter)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC FORM 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION FORM 8-K ROADRUNNER TRANSPORTATION SYSTEMS, INC.

SECURITIES AND EXCHANGE COMMISSION FORM 8-K. Current report filing

Oracle Corporation (Exact name of registrant as specified in its charter)

TELENAV, INC. FORM 8-K. (Current report filing) Filed 10/30/14 for the Period Ending 10/30/14

BARRETT BUSINESS SERVICES, INC. (Exact name of registrant as specified in charter)

3M CO FORM 8-K. (Current report filing) Filed 10/23/12 for the Period Ending 10/23/12

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C FORM 8-K. 3M COMPANY (Exact Name of Registrant as Specified in Its Charter)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C FORM 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C FORM 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C FORM 8-K

Oracle Corporation (Exact name of registrant as specified in its charter)

Aspen Aerogels, Inc. (Exact name of Registrant as Specified in Its Charter)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION FORM 8-K HAYNES INTERNATIONAL, INC.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C Form 8-K

Transcription:

form8k.htm 8-K 1 form8k.htm FORM 8-K 2-7-2014 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): February 6, 2014 CTS CORPORATION (Exact Name of Registrant as Specified in Its Charter) Indiana 1-4639 35-0225010 (State or Other Jurisdiction of Incorporation) (Commission File Numbers) (I.R.S. Employer Identification Nos.) 905 West Boulevard North Elkhart, Indiana 46514 (Address of Principal Executive Offices) (Zip Code) Registrants' Telephone Number, Including Area Code: (574) 523-3800 (Former Name or Former Address, if Changed Since Last Report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: q Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) q q q Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Item 2.02 Results of Operations and Financial Condition. On February 6, 2014, CTS Corporation (the Registrant ) issued a press release providing certain results for the fourth quarter and year ended December 31, 2013 as more fully described in the press release. A copy of the press release announcing the Registrant s results for the fourth quarter and year ended December 31, 2013 is attached hereto as Exhibit 99.1 and incorporated by reference herein. The information contained in Item 2.02 of this Current Report on Form 8-K, including Exhibit 99.1 attached hereto, is being furnished to the Securities and Exchange Commission and shall not be deemed to be "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that Section. Furthermore, the information contained in Item 2.02 of this Current Report on Form 8-K shall not be deemed to be incorporated by reference into any registration statement or other document filed pursuant to the Securities Act of 1933. http://www.sec.gov/archives/edgar/data/26058/000002605814000005/form8k.htm[1/18/2016 9:01:14 AM]

form8k.htm Item 2.02 Results of Operations and Financial Condition. On February 6, 2014, CTS Corporation (the Registrant ) issued a press release providing certain results for the fourth quarter and year ended December 31, 2013 as more fully described in the press release. A copy of the press release announcing the Registrant s results for the fourth quarter and year ended December 31, 2013 is attached hereto as Exhibit 99.1 and incorporated by reference herein. The information contained in Item 2.02 of this Current Report on Form 8-K, including Exhibit 99.1 attached hereto, is being furnished to the Securities and Exchange Commission and shall not be deemed to be "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that Section. Furthermore, the information contained in Item 2.02 of this Current Report on Form 8-K shall not be deemed to be incorporated by reference into any registration statement or other document filed pursuant to the Securities Act of 1933. Item 9.01 Financial Statements and Exhibits. (d) Exhibits. The following exhibits are filed with this report: Exhibit No. Exhibit Description 99.1 Press Release dated February 6, 2014 SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. CTS CORPORATION /s/ Robert J. Patton By: Robert J. Patton Vice President, General Counsel and Secretary Date: February 7, 2014 http://www.sec.gov/archives/edgar/data/26058/000002605814000005/form8k.htm[1/18/2016 9:01:14 AM]

form8k.htm SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. CTS CORPORATION /s/ Robert J. Patton By: Robert J. Patton Vice President, General Counsel and Secretary Date: February 7, 2014 EXHIBIT INDEX Exhibit No. Exhibit Description 99.1 Press Release dated February 6, 2014 http://www.sec.gov/archives/edgar/data/26058/000002605814000005/form8k.htm[1/18/2016 9:01:14 AM]

form8k.htm EXHIBIT INDEX Exhibit No. Exhibit Description 99.1 Press Release dated February 6, 2014 http://www.sec.gov/archives/edgar/data/26058/000002605814000005/form8k.htm[1/18/2016 9:01:14 AM]

EX-99.1 2 ex99_1.htm EXHIBIT 99.1 FEBRUARY 6, 2014 newsrelease CTS CORPORATION Elkhart, Indiana 46514 574-523-3800 February 6, 2014 FOR RELEASE: Immediately CTS ANNOUNCES FOURTH QUARTER AND FULL-YEAR 2013 RESULTS 2013 Results Within Guidance Continues to Simplify, Focus and Drive Profitable Growth Elkhart, IN...CTS Corporation (NYSE: CTS) today announced fourth quarter and full-year 2013 financial results. The EMS segment was divested on October 2nd 2013 for $75 million, and is now reported as discontinued operations. Fourth Quarter 2013 Results Sales from continuing operations were $102.4 million, a 35% increase from fourth quarter of 2012. GAAP loss per share was $0.09 compared to earnings per share of $0.26 in the same period last year. Adjusted EPS was $0.25 compared to $0.18 in fourth quarter of 2012. In the fourth quarter, sales from continuing operations increased 35% from fourth quarter of 2012. Electronic component sales grew 7% helped by demand for piezo-ceramic products. The sensors and mechatronic product sales grew 56% primarily driven by the acquisition of D&R Technologies and the rebound in automobile production volumes. We booked $78 million in new orders in the fourth quarter. 2013 Full-Year Results Sales from continuing operations were $409.5 million, an increase of 34% from 2012. GAAP loss per share was $0.12 compared to earnings per share of $0.59 for 2012. Adjusted EPS was $0.82 compared to $0.64 in 2012. Cash from operating activities was $38 million compared to $41.7 million in 2012. Capital expenditures were $14.0 million compared to $13.5 million in 2012. Full-year sales from continuing operations increased 34%. Electronic component sales increased 15% driven by higher demand for piezo-ceramic products. Sensors and Mechatronics grew 48% from the acquisition of D&R Technologies and an increase in automobile production volumes. Commenting on the 2013 results, Kieran O Sullivan, CEO, stated, 2013 and 2014 are transitional years for CTS. Last year, we developed a clear strategic plan. We simplified our business model by divesting the non-core EMS segment and strengthened our balance sheet. At the same time, we initiated footprint rationalization projects to improve our cost structure. These projects are progressing according to plan. In addition, we strengthened our leadership team. In 2014, we will continue to focus on strengthening our core Components and Sensors business by increasing sales and marketing presence closer to target customers. Our investment in research and development for new products remains strong. We believe that these steps will position CTS to drive profitable growth. Looking ahead, management anticipates full-year 2014 sales to increase in the range of 4% to 6% over 2013 while continuing to carefully monitor the trend in emerging markets. Diluted earnings per share is expected to be in the range of $0.96 to $1.02. Results are expected to show continuous improvement through the year, with a stronger second half. Conference Call As previously announced, the Company has scheduled a conference call on Friday, February 7, 2014 at 11:00 a.m. EST. The dial-in number for the conference call is 888-523-1228 (719-785-1753, if calling from outside the U.S.). The conference I.D. number is 2552181. There will be a replay of the conference call from 3:00 p.m. (EST) on Friday, February 7, 2014 through 3:00 p.m. (EST) on Friday, February 14, 2014. The telephone number for the replay is 888-203-1112 (719-457-0820, if calling from outside the U.S.). The access code is 2552181. Also, please note that a live audio webcast of the conference call will be available and can be accessed directly from the website of CTS Corporation www.ctscorp.com. About CTS

CTS is a leading designer and manufacturer of electronic components and sensors to OEMs in the automotive, communications, medical, defense and aerospace, industrial and computer markets. CTS manufactures products in North America, Europe and Asia. CTS' stock is traded on the NYSE under the ticker symbol "CTS. Safe Harbor This document contains statements that are, or may be deemed to be, forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include, but are not limited to, any financial or other guidance, statements that reflect our current expectations concerning future results and events, and any other statements that are not based solely on historical fact. Forwardlooking statements are based on management's expectations, certain assumptions and currently available information. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof and are based on various assumptions as to future events, the occurrence of which necessarily are subject to uncertainties. These forward-looking statements are made subject to certain risks, uncertainties and other factors, which could cause our actual results, performance or achievements to differ materially from those presented in the forward-looking statements. Examples of factors that may affect future operating results and financial condition include, but are not limited to: changes in the economy generally and in respect to the businesses in which CTS operates; unanticipated issues in integrating acquisitions; the results of actions to reposition our businesses; rapid technological change; general market conditions in the automotive, communications, and computer industries, as well as conditions in the industrial, defense and aerospace, and medical markets; reliance on key customers; unanticipated natural disasters or other events; the ability to protect our intellectual property; pricing pressures and demand for our products; and risks associated with our international operations, including trade and tariff barriers, exchange rates and political and geopolitical risks. Many of these, and other, risks and uncertainties are discussed in further detail in Item 1.A of the Annual Report on Form 10-K. We undertake no obligation to publicly update our forward-looking statements to reflect new information or events or circumstances that arise after the date hereof, including market or industry changes. Contact: Ashish Agrawal, Vice President and Chief Financial Officer CTS Corporation, 905 West Boulevard North, Elkhart, IN 46514 Telephone 574-523-3800 CTS CORPORATION AND SUBSIDIARIES CONDENSED CONSOLIDATED STATEMENTS OF EARNINGS / (LOSS) - UNAUDITED (In thousands, except per share amounts) Three Months Ended Twelve Months Ended December 31, December 31, December 31, December 31, 2013 2012 2013 2012 Net sales $ 102,386 $ 75,675 $ 409,461 $ 304,481 Costs and expenses: Cost of goods sold 72,220 53,290 288,108 212,965 Insurance recovery for business interruption - (637) - (637) Selling, general and administrative expenses 17,227 17,699 69,889 63,071 Research and development expenses 5,481 5,328 23,222 20,918 Gain on sale-leaseback - (10,334) - (10,334) Restructuring charge 2,348 2,588 10,455 3,437 Operating earnings 5,110 7,741 17,787 15,061 Other income / (expense): Interest income / (expense), net 19 (311) (1,463) (849) Other income 1,359 414 1,739 232 Total other income / (expense) 1,378 103 276 (617) Earnings before income taxes 6,488 7,844 18,063 14,444

CTS CORPORATION AND SUBSIDIARIES CONDENSED CONSOLIDATED STATEMENTS OF EARNINGS / (LOSS) - UNAUDITED (In thousands, except per share amounts) Three Months Ended Twelve Months Ended December 31, December 31, December 31, December 31, 2013 2012 2013 2012 Net sales $ 102,386 $ 75,675 $ 409,461 $ 304,481 Costs and expenses: Cost of goods sold 72,220 53,290 288,108 212,965 Insurance recovery for business interruption - (637) - (637) Selling, general and administrative expenses 17,227 17,699 69,889 63,071 Research and development expenses 5,481 5,328 23,222 20,918 Gain on sale-leaseback - (10,334) - (10,334) Restructuring charge 2,348 2,588 10,455 3,437 Operating earnings 5,110 7,741 17,787 15,061 Other income / (expense): Interest income / (expense), net 19 (311) (1,463) (849) Other income 1,359 414 1,739 232 Total other income / (expense) 1,378 103 276 (617) Earnings before income taxes 6,488 7,844 18,063 14,444 Income tax expense 1,811 1,913 16,066 952 Earnings from continuing operations 4,677 5,931 1,997 13,492 (Loss) / earnings from discontinued operations, net of tax (7,658) 2,901 (5,926) 6,841 Net earnings $ (2,981) $ 8,832 $ (3,929) $ 20,333 Net earnings / (loss) per share: Basic Continuing operations $ 0.14 $ 0.17 $ 0.06 $ 0.40 Discontinued operations (0.23) 0.09 (0.18) 0.20 Net (loss) earnings attributable to CTS Corporation $ (0.09) $ 0.26 (0.12) $ 0.60 Diluted Continuing operations $ 0.14 $ 0.17 0.06 $ 0.39 Discontinued operations (0.23) 0.09 (0.18) 0.20 Net (loss) earnings attributable to CTS Corporation $ (0.09) $ 0.26 (0.12) $ 0.59 Cash dividends declared per share $ 0.040 $ 0.035 $ 0.145 $ 0.140 Average common shares outstanding: Basic 33,594 33,640 33,601 33,922 Diluted 34,314 34,330 34,249 34,523

CTS CORPORATION AND SUBSIDIARIES OTHER SUPPLEMENTAL INFORMATION Earnings / (Loss) per Share The following table reconciles GAAP earnings per share to adjusted earnings per share for the Company: Three Months Ended Twelve Months Ended December 31, December 31, December 31, December 31, 2013 2012 2013 2012 GAAP (loss) / earnings per share $ (0.09) $ 0.26 $ (0.12) $ 0.59 Tax affected charges to reported diluted earnings / (loss) per share: Restructuring and related charges 0.08 0.09 0.28 0.19 Additional legal costs - 0.02-0.04 CEO transition costs 0.03-0.07 0.01 Tax impact of cash repatriation - - 0.31 - Tax asset write-off related to restructuring - - 0.03 - Acquisition-related costs - 0.04-0.04 Gain on sale-leaseback - (0.23) - (0.23) EMS divestiture 0.23-0.25 - Adjusted earnings per share $ 0.25 $ 0.18 $ 0.82 $ 0.64 Additional Information The following table includes other financial information not presented in the preceding financial statements. Three Months Ended Twelve Months Ended $ In thousands December 31, December 31, December 31, December 31, Expense 2013 2012 2013 2012 Depreciation and Amortization $ 4,492 $ 4,372 $ 21,169 $ 19,615 Equity Based Compensation $ 1,078 $ 382 $ 4,219 $ 4,099 OTHER SUPPLEMENTAL INFORMATION (continued) Non-GAAP Financial Measures Adjusted earnings/(loss) per share is a non-gaap financial measure. The most directly comparable GAAP financial measure is diluted earnings/(loss) per share. CTS adjusts for this item because they are discrete events which have a significant impact on comparable GAAP financial measures and could distort an evaluation of our normal operating performance.

OTHER SUPPLEMENTAL INFORMATION (continued) Non-GAAP Financial Measures Adjusted earnings/(loss) per share is a non-gaap financial measure. The most directly comparable GAAP financial measure is diluted earnings/(loss) per share. CTS adjusts for this item because they are discrete events which have a significant impact on comparable GAAP financial measures and could distort an evaluation of our normal operating performance. CTS uses an adjusted earnings/(loss) per share measure to evaluate overall performance, establish plans and perform strategic analysis. Using this measure avoids distortion in the evaluation of operating results by eliminating the impact of events which are not related to normal operating performance. Because this measure is based on the exclusion or inclusion of specific items, they may not be comparable to measures used by other companies which have similar titles. CTS' management compensates for this limitation when performing peer comparisons by evaluating both GAAP and non-gaap financial measures reported by peer companies. CTS believes that this measure is useful to its management, investors and stakeholders in that it: - provides a truer measure of CTS' operating performance, - reflects the results used by management in making decisions about the business, and - helps review and project CTS' performance over time. We recommend that investors consider both actual and adjusted measures in evaluating the performance of CTS with peer companies. CTS Corporation and Subsidiaries Condensed Consolidated Balance Sheets - Unaudited (In thousands of dollars) December 31, December 31, 2013 2012 Cash and cash equivalents $ 124,368 $ 109,571 Accounts receivable, net 62,667 89,342 Inventories 32,226 81,752 Other current assets 17,007 28,633 Total current assets 236,268 309,298 Property, plant & equipment, net 74,870 93,725 Other assets 169,127 158,156 Total Assets $ 480,265 $ 561,179 Notes payable and current portion of long-term debt $ - $ - Accounts payable 47,052 67,973 Accrued liabilities 47,902 47,056

CTS Corporation and Subsidiaries Condensed Consolidated Balance Sheets - Unaudited (In thousands of dollars) December 31, December 31, 2013 2012 Cash and cash equivalents $ 124,368 $ 109,571 Accounts receivable, net 62,667 89,342 Inventories 32,226 81,752 Other current assets 17,007 28,633 Total current assets 236,268 309,298 Property, plant & equipment, net 74,870 93,725 Other assets 169,127 158,156 Total Assets $ 480,265 $ 561,179 Notes payable and current portion of long-term debt $ - $ - Accounts payable 47,052 67,973 Accrued liabilities 47,902 47,056 Total current liabilities 94,954 115,029 Long-term debt 75,000 153,500 Other obligations 13,416 24,892 Shareholders' equity 296,895 267,758 Total Liabilities and Shareholders' Equity $ 480,265 $ 561,179